With the rapidly evolving regulatory landscape, staying on top of the latest updates is crucial for companies in biopharma and medical devices. In this briefing, we highlight recent regulatory and legislative developments...more
The skinny on President Trump’s slimmed down Fiscal Year 2018 budget is anything but positive for advocates of medical research.
In a White House budget officially released the morning of Thursday, March 16, the...more